The information on this website is intended to provide scientific information about Alkermes products and areas of therapeutic interest. Information may include data on investigational uses of approved or unapproved drugs for which safety and effectiveness have not been established. There is no guarantee that such uses will receive health authority approval and Alkermes does not recommend or suggest use of its medicines in a manner inconsistent with approved labeling.

This section includes selected Alkermes abstracts, posters or oral presentations, which have been accepted for congress presentations in the last 2 years. The content contained in this section is subject to congress copyright permissions.

POSTER
Risk Evaluation and Mitigation Strategies: From Burden to Benefit
Author(s):

Lindsay M. McCullough, MD1; Craig Chepke, MD2; Richard K. Bogan, MD3,4; Martha Curtin, MSPA, PA-C5; Diana Anderson, DMS, PA-C6; Jennifer Gudeman, PharmD7,a; Marla Scarola, MS6; Tracy Gentile, BA8; Danielle Burroughs, RPh6
 

1Department of Medicine, Rush University Medical Center, Chicago, IL, USA; 2Excel Psychiatric Associates, Huntersville, NC, USA; 3University of South Carolina School of Medicine, Columbia, SC, USA; 4Medical University of South Carolina, Charleston, SC, USA; 5Suburban Sleep, Joliet and Rolling Meadows, IL, USA; 6Alkermes, Inc., Waltham, MA, USA*; 7Avadel Pharmaceuticals, Chesterfield, MO, USA; 8UBC, King of Prussia, PA, USA; aAt the time of publication development

Content available until 06/14/2029